Press release
Glycopeptide Antibiotics Market: Analysis, Trends & Forecast 2024-2033 | Growth, Size & Share Insights
Glycopeptide Antibiotics Market
The glycopeptide antibiotics market size is expected to see strong growth in the next few years. It will grow to $5.02 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emerging infectious diseases, increasing geriatric population, continued antibiotic resistance challenges, r&d investments and innovations, expansion of healthcare infrastructure. Major trends in the forecast period include increasing antibiotic resistance, advancements in research and development, global health emergencies driving demand, collaborations for antibiotic stewardship, market expansion in emerging economies.
Market Overview -
Glycopeptide antibiotics are a group of antibiotics having structures that either comprise a glycosylated cyclic or polycyclic non-ribosomal peptide, used to inhibit bacterial cell wall formation. They were first discovered from plant and soil bacteria.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9444&type=smp
The Surging Demand For Glycopeptide Antibiotics In The Face Of Rising Cancer And Infectious Disease Cases
The rising number of cancer and infectious disease cases is expected to propel the growth of the glycopeptide antibiotics market going forward. Cancer refers to a disease that occurs when certain body cells multiply beyond their limits and spread to other body regions, whereas, infectious diseases are disorders produced by organisms such as bacteria, viruses, fungus, or parasites. The glycopeptide antibiotics are used to treat a variety of infectious disorders caused by methicillin-resistant staphylococcus aureus, streptococcus, or enterococcus bacteria that are resistant to beta-lactams and other antibiotics. In cancer patients, glycopeptide antibiotics are used to boost radiotherapy's antitumor effects by eliminating not only the targeted cancer cells but also distant cancer cells farther in the body. For instance, according to the American Cancer Society, a US-based non-profit health organization committed to cancer eradication, in 2022, the US had 1.9 million new cancer cases and 609,360 cancer deaths, for a total of 1,670 fatalities each day. Therefore, the rising cancer and infectious disease cases will drive the growth of the glycopeptide antibiotics market.
Competitive Landscape -
Major companies operating in the glycopeptide antibiotics market report are ANI Pharmaceuticals Inc., Fresenius SE & Co. KGaA, Pfizer Inc., Mylan N.V., Novartis AG, Hikma Pharmaceuticals Plc., Aurobindo Pharma Limited, Abbvie Inc., Melinta Therapeutics Inc., Cumberland Pharmaceuticals Inc., Theravance Biopharma Inc., Janssen Global, Bristol-Myers Squibb Company, GSK Plc., Allergan Plc., Shenwei Pharmaceutical Hainan Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd., Lytix Biopharma, Alvogen, Eli Lilly and Company, Bayer AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi SA, Targanta Therapeutics, GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim GmbH, Cipla Inc. .
Leiden University's Breakthrough Discovery Of Enhanced Vancomycin Variants Marks A Milestone In Glycopeptide Innovation
Product innovation is a key trend gaining popularity in the glycopeptide antibiotics market. Major companies operating in the glycopeptide antibiotics market are focused on developing innovative products to strengthen their position in the market. For instance, In October 2022, Leiden University, a Netherlands-based research university, discovered new variants of the antibiotic vancomycin. A group of molecules was attached to the structure of an existing vancomycin molecule to create the new variant antibiotic vancomycin. The new variant of vancomycin is up to a thousand times more active against gram-positive bacteria than the original vancomycin and has lower nephrotoxicity when compared to commercially utilized polymyxin antibiotics. This was created to solve the problem since vancomycin can only be effective against gram-positive strains and it cannot pass through the outer membrane (OM) of gram-negative bacteria.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report
Key Segments -
The glycopeptide antibiotics market covered in this report is segmented -
1) By Drug: Vancomycin, Dalbavancin, Oritavancin, Other Drugs
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By Indication: Skin And Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Other Indications
4) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glycopeptide Antibiotics Market: Analysis, Trends & Forecast 2024-2033 | Growth, Size & Share Insights here
News-ID: 3482572 • Views: …
More Releases from The Business research company
Global Light Commercial Vehicle Market Overview Covering Forecast Market Size An …
"The light commercial vehicle market size has grown rapidly in recent years. It will grow from $614.93 billion in 2023 to $676.49 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to industrialization and economic growth, urbanization and infrastructure development, small business and entrepreneurship, evolving consumer preferences.
The light commercial vehicle market size is expected to see…
Hand Dryers Market 2024 Report By Key Companies, Regional Analysis And Forecast …
The hand dryers market size has grown rapidly in recent years. It will grow from $1.97 billion in 2023 to $2.2 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to hygiene and sanitation awareness, environmental concerns, cost savings, government regulations.
The hand dryers market size is expected to see rapid growth in the next few years.…
Fungicides Market Trends, Top Companies, Share, Growth And Forecast 2033
The fungicides market size has grown strongly in recent years. It will grow from $22.83 billion in 2023 to $24.57 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to crop protection, crop expansion, climate conditions, pesticide resistance management.
The fungicides market size is expected to see strong growth in the next few years. It will grow to…
Interventional Cardiology Devices And Equipment Market Analysis 2024-2033 : Fore …
"The interventional cardiology devices and equipment market size has grown strongly in recent years. It will grow from $14.1 billion in 2023 to $15.48 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, patient demand for minimally invasive procedures, clinical guidelines and research.
The interventional cardiology devices and equipment market size is…
More Releases for Glycopeptide
Glycopeptide Antibiotics Market Size, Analytical Overview, Growth Factors, Deman …
Glycopeptide antibiotics Market survey report offers key information about the industry, helpful and important facts and figures, expert opinions, and the latest developments across the world. This market report includes data on patterns and improvements, target business sectors and materials, limits, and advancements. In this report, methodical SWOT analysis & investment analysis is performed which forecasts forthcoming opportunities for the market players. The report on the global market is a…
Glycopeptide Antibiotics Market 2020 Global Industry Size, Growth, Segments with …
When globalization is growing day by day, many businesses call for global market research consisting of actionable market insights that helps with decision making. This Glycopeptide Antibiotics Market analysis report gives out the data for industry about company profile, product specifications, capacity, production value, and market shares for each company for the year 2020 to 2026 under the competitive analysis study. The business report is prepared with the systematic gathering…
Glycopeptide Antibiotics Market 2020 Global Industry Size, Share, Trends and Tec …
This influential Glycopeptide Antibiotics Market report is a wonderful guide to achieve information or key data about market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand positioning, customer preferences & customer behaviour. The market report definitely offers a great motivation to businesses to seek new business ventures and evolve better. Businesses can economically bring into play the data, statistics, research, and insights about the market included in…
Covid-19 impact on - Glycopeptide Antibiotics Market 2020 Industry Research, Sha …
The report endows with important information about the elements that are impacting and driving the sales of the Glycopeptide Antibiotics Market. The section of competitive landscape keeps utmost importance in the report which consists of key market players functioning in the worldwide Healthcare industry. According to this report, several macroeconomic factors such as gross domestic product (GDP) and the increasing inflation rate are expected to affect directly or indirectly in…
Global Peptide Therapeutics Pipeline Insight 2015
Peptides are small molecules of varying molecular masses that consist of amino acids joined with the help of peptide bonds (CONH2). One end of the molecule consists of carboxyl (COOH2) group while the other end has amino (NH2) group giving rise to polarity. Biologically, they are very important and found to play an important role in various anabolic and catabolic processes. They are essential component of cell signaling pathways, immune…
PREMIER Biosoft International Releases SimGlycan® 3.00 with Support for Qualita …
Palo Alto, California – May 25, 2011, PREMIER Biosoft International today announced the worldwide release of version 3.00 of its high throughput multi-stage MS data analysis tool, SimGlycan®. The program now includes support for Qualitative Glycopeptide Analysis, enabling users to resolve complex glycopeptides using data obtained from an LC-MS/MS run of proteolytically digested purified glycoproteins.
“The glycopeptide qualitative analysis module in SimGlycan employs powerful algorithms to obtain critical information for understanding…
